Cure pharmaceutical issues letter to shareholders

Oxnard, calif.--(business wire)--cure pharmaceutical holdings (“cure” or the “company”) (otc: curr), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today that it has issued a letter to its shareholders providing commentary on the company's recent announcements and upcoming plans. highlights of the letter include: the company's efforts to further position itself as an integrated healthcare company with its recent acquisiti
CURR Ratings Summary
CURR Quant Ranking